Published in
Royal Society of Chemistry, RSC Advances, 40(7), p. 24828-24832
DOI: 10.1039/c7ra04606e
Links
Tools
Use of a next generation maleimide in combination with THIOMAB™ antibody technology delivers a highly stable, potent and near homogeneous THIOMAB™ antibody-drug conjugate (TDC)
Journal article published in 2017 by
João P. M. Nunes,
Vessela Vassileva,
Eifion Robinson,
Maurício Morais 
,
Mark E. B. Smith,
R. Barbara Pedley,
Stephen Caddick,
James R. Baker ,
Vijay Chudasama
,
Mark E. B. Smith,
R. Barbara Pedley,
Stephen Caddick,
James R. Baker ,
Vijay Chudasama
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Data provided by 